Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Feb;104(2):167-78; quiz 179.
doi: 10.1007/s00347-007-1481-5.

[Primary open angle glaucoma. Morphological bases for the understanding of the pathogenesis and effects of antiglaucomatic substances]

[Article in German]
Affiliations
Review

[Primary open angle glaucoma. Morphological bases for the understanding of the pathogenesis and effects of antiglaucomatic substances]

[Article in German]
E Lütjen-Drecoll et al. Ophthalmologe. 2007 Feb.

Abstract

The pathogenesis of glaucomatic illnesses is poorly understood. An increase in ocular pressure can be caused by an increase in the secretion of aqueous humour or a reduction in its outflow. In the elderly, outflow is reduced while at the same time less aqueous humour is produced. This balance is easily disturbed, so that age represents a risk factor for glaucoma in addition to increased ocular pressure. Therapeutic possibilities involve, on the one hand, reducing the secretion of aqueous humour, for example using, beta blockers, carbonic anhydrase inhibitors and clonidine. On the other hand, aqueous humour outflow can also be influenced by drugs. Conventional outflow is increased by the administration of miotics. The uveoscleral outflow can be increased by prostaglandin derivates. Drugs which only influence trabecular outflow are not yet available. Future therapeutic possibilities involve new aspects of the pathophysiology, e.c. the use of growth factors, free radical scavenging enzymes and choroidal blood flow.

PubMed Disclaimer

References

    1. Invest Ophthalmol Vis Sci. 2005 Feb;46(2):568-78 - PubMed
    1. Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2184-91 - PubMed
    1. Exp Eye Res. 1988 Dec;47(6):885-99 - PubMed
    1. Curr Eye Res. 2005 May;30(5):337-44 - PubMed
    1. Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4419-26 - PubMed

MeSH terms

LinkOut - more resources